TITLE

California's 1st Stem Cell Deal Will Be in Variable-Rate Mode

AUTHOR(S)
Saskal, Rich
PUB. DATE
May 2007
SOURCE
Bond Buyer;5/22/2007, Vol. 360 Issue 32634, p36
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports that California's forthcoming stem cell bonds will be sold in variable-rate form. Voters have authorized $3 billion of general obligation bonds to finance medical research using stem cells. The author also offers information about the tax status of bonds issued for stem cell research.
ACCESSION #
25219307

Tags: RESEARCH -- Finance;  STEM cells -- Research;  BONDS (Finance);  NEGOTIABLE instruments

 

Related Articles

  • California Voters Will Decide Fate Of $3B of GOs for Stem Cell Researcxh. Saskal, Rich // Bond Buyer;6/4/2004, Vol. 348 Issue 31898, p4 

    Reports that Californians will vote in November 2004 on a proposed $3 billion general obligation bond to fund embryonic stem cell research. Key issues of interest; Analysis of pertinent topics and relevant issues; Implications on the bond market and genetic research.

  • Panel OKs Money for Stem Cell Clinical Trials. Chambers, Heather // San Diego Business Journal;3/15/2010, Vol. 31 Issue 11, p8 

    The article reports that the governing board for the state's three billion dollars stem cell institute approved the funding for the development of new stem cell therapies in San Diego, California.

  • With Lawsuit Dead, California Is Free to Sell Stem Cell Bonds. Saskal, Rich // Bond Buyer;5/18/2007, Vol. 360 Issue 32632, p40 

    The article reports on the sale of bonds to finance medical research using stem cells as soon as it is practical after the demise of a lawsuit that had delayed them for more than two years in California. Voters have approved Proposition 71 authorizing $3 billion of general obligation bonds for...

  • California Makes $150M Stem Cell Loan. Saskal, Rich // Bond Buyer;7/21/2006, Vol. 357 Issue 32428, p4 

    The article reports that California Governor Arnold Schwarzenegger has authorized a $150 million general fund loan to the state's stem cell research institute. The California Institute for Regenerative Medicine was established in 2004 after voters approved a ballot measure authorizing $3 billion...

  • Court paints with broad brush, upends U.S. stem cell policy. Lefkowitz, Jay // Hill;9/16/2010, Vol. 17 Issue 100, p31 

    In this article the author focuses on the court ruling which emphasized the preclusion of an embryonic stem cell research project from receiving federal fundings by the Dickey-Wicker Amendment if one step of the project results in the destruction of an embryo in the U.S.

  • Stem-cell research must go forward. Harkin, Tom // Hill;10/6/2010, Vol. 17 Issue 110, p23 

    The article reports on the author's thoughts about the impact of the decision of U.S. District Judge Royce Lamberth on halting federal funding for embryonic stem-cell research on one of the fields of biomedical inquiry which is considered promising.

  • Stem Cell Research Funding: Policy and Law.  // New Atlantis: A Journal of Technology & Society;Winter2012, Vol. 34, p114 

    An appendix is presented that shows the stem cell research funding in the U.S.

  • US BRIEFS.  // National Catholic Reporter;10/1/2010, Vol. 46 Issue 25, p3 

    The article offers news briefs related to the Catholic Church in the U.S. including then immediate resignation of Bishop Charles Bennison, opposition against stem-cell research funding, and the Federal Bureau of Investigation's surveillance at Thomas Merton Center.

  • Market Indicators .  // Bond Buyer;1/24/2002, Vol. 339 Issue 31310, p33 

    Focuses on the market indicators for transaction of bonds during 2002 and 2003. Total volume of bonds in terms of dollar; Index for bonds developed by Bond Buyer; Sales of bonds.

Share

Read the Article

Courtesy of your local library

Public Libraries Near You (See All)
Looking for a Different Library?

Other Topics